Overview
This 2.5 day workshop will cover the latest advances in the application of MR to cancer research, and will feature invited scientific presentations, proffered papers, a poster session, debates, and the Negendank memorial lecture on a special topic of clinical relevance.

Educational objectives

At the conclusion of the meeting participants should be able to

· Describe standard cancer treatment strategies;

· List current challenges for obtaining individualized cancer treatment;

· Compare and evaluate several newly emerging Cancer MR biomarkers;

· List four independent MR assessments of treatment effects;

· Assess the role of MR in evaluating new cancer drugs;

· Effectively deliver MR information to clinicians so they can make best use of it for cancer treatment assessment;

· Explain how PET and MR may be used to improve patient treatment; and

· Compare two MR approaches for clinical routne evaluation of treatment response.



Audience Description

This workshop will be presented at an intermediate – advanced skill level, and is designed for:

Basic scientists and physicians who use MR in cancer research;
Clinicians (oncologists, radiologists, pathologists, surgeons);
Industry scientists employing MR imaging and spectroscopy in pharmaceutical or contrast agent/molecular imaging companies;
Basic scientists and physicians with particular interests in methodological development of in vivo MRS and MRI; and
Basic scientists and physicians using MR in drug research.